Found 3 results

Author Title Type [ Year]

Filters: Author is Liu, D  [Clear All Filters]

2017

J. D. Lee, Jr, E. V. Nunes, Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., Peavy, K. M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablien, D., Subramaniam, G., and Rotrosen, J., “Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial”, Lancet, 2017.

2016

J. D. Lee, Nunes, E. V., Novo, P., Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., “NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale”, Contemp Clin Trials, 2016.

2012

T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., Van Veldhuisen, P., Adinoff, B., and Somoza, E., “Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World”, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.